Skip to main content
Equibles
AHR logo

AHR · American Healthcare REIT, Inc.

Track AHR — free

Use AHR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about AHR

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$54.31 +0.71 (+1.32%) At close · Aug 14
Market Cap
$11.83B
Shares
218.00M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$54.31 Open$54.01 Day$53.54–54.52 52W close$40.18–57.72 Avg vol 30d2.8M Short int22.1M · 10.2% float · 9.7d Short vol42% Last earningsAug 7, 2026 DataFeb 2024–Aug 2026 Filing10-Q · Aug 7

Up next

Next earnings call
Nov 6, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 7, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Neutral Sentiment Neutral Fundamentals Fair Quant / Vol Low
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +9%
      above
      Price vs 50-day avg +3%
      above
      RSI (14) 49
      neutral
      MACD trend Negative
      52-week position 81%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Neutral
      1-month return −5%
      trailing
      6-month return +3%
      trailing
      YTD return +15%
      this year
      Relative strength −11%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $53 › 200d $50 — 50d above 200d
      Institutional flow Accumulating
      +8% holders QoQ · +95 funds added
      Insider flow Distributing
      Net -$1.4M over 90 days · 100% sells
      Short interest Rising
      10.16% of float · ▲ +1.0% MoM · 9.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      559 holders — near 2-yr high, broad support
      Squeeze score 83
      high risk · 0–100
      Fundamentals
      Fair
      Revenue growth +9%
      Y/Y
      EPS growth +245%
      Y/Y
      Valuation P/E 78.6
      rich
      Balance sheet $870.7M
      net debt
      Quant / Vol
      risk profile
      Low
      Volatility 26%
      annualized · 1-yr
      Max drawdown −14%
      past year
      ATR 2.9%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 6, 2026
      Same-Store NOI growth (total portfolio) · year ending December 31, 2026 11% – 13%
      NFFO per diluted share · year ending December 31, 2026 Non-GAAP $2.15 – $2.19
      Prior guidance period ended · from the 8-K filed Nov 6, 2025
      Same-Store NOI growth · year ending December 31, 2025 13% – 15%
      Normalized Funds from Operations (NFFO) per diluted share · year ending December 31, 2025 $1.69 – $1.72

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +9% Bullish
      Price vs 50-day avg
      +3% Bullish
      RSI (14)
      49 Neutral
      MACD trend
      Negative Bearish
      52-week position
      81% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $53 › 200d $50 — 50d above 200d
      Institutional flow Accumulating
      +8% holders QoQ · +95 funds added
      Insider flow Distributing
      Net -$1.4M over 90 days · 100% sells
      Short interest Rising
      10.16% of float · ▲ +1.0% MoM · 9.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      559 holders — near 2-yr high, broad support
      Price context
      position in its 52-week range
      Range low $40 Now $54 · 81% Range high $58
      vs 200-day avg +9% vs 50-day avg +3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted EBITDA non-GAAP 124.99M Three Months Ended June 30, 2026 —
      GAAP → non-GAAP reconciliation
      GAAP EBITDA $122.16M
      -$892K Income from unconsolidated entities
      -$486K Straight line rent and amortization of above/below market leases
      +$5.77M Non-cash impact of changes to equity instruments
      +$2.79M Transaction, transition and restructuring costs
      -$5.65M Gain on dispositions of real estate investments, net
      +$12K Amortization of closing costs — debt security investment
      -$75K Foreign currency gain
      -$357K Gain in fair value of derivative financial instruments
      +$1.72M Impairment of real estate investments
      = Adjusted EBITDA $124.99M
      Average operator Occupancy (Triple-Net Leased Properties) 90.5% Q2 2026 —
      Cash NOI non-GAAP 274.22M Six Months Ended June 30, 2026 —
      Consolidated average Occupancy (ISHC) 89.5% Q2 2026 —
      Consolidated average Occupancy (SHOP) 88.8% Q2 2026 —
      Ending Occupancy (Outpatient Medical) 88.4% Q2 2026 —
      NAREIT FFO attributable to controlling interest 188.33M Six Months Ended June 30, 2026 —
      NAREIT FFO per common share attributable to controlling interest — diluted $0.99 Six Months Ended June 30, 2026 —
      Net operating income 262.74M Six Months Ended June 30, 2026 —
      Normalized FFO attributable to controlling interest non-GAAP 200M Six Months Ended June 30, 2026 —
      Normalized FFO per common share attributable to controlling interest — diluted non-GAAP $1.05 Six Months Ended June 30, 2026 —
      Pro-Rata Annualized Cash NOI (Total) non-GAAP $571.84M Q2 2026 —
      Same-Store NOI (ISHC) non-GAAP $71.35M Q2 2026 —
      Same-Store NOI (Outpatient Medical) non-GAAP $17.39M Q2 2026 —
      Same-Store NOI (SHOP) non-GAAP $16.09M Q2 2026 —
      Same-Store NOI (Total Portfolio) non-GAAP $112.29M Q2 2026 —
      Same-Store NOI (Triple-Net Leased Properties) non-GAAP $7.46M Q2 2026 —
      Same-Store properties (ISHC) 115 For the Six Months Ended June 30, 2026 —
      Same-Store properties (OM) 65 For the Six Months Ended June 30, 2026 —
      Same-Store properties (SHOP) 64 For the Six Months Ended June 30, 2026 —
      Same-Store properties (Triple-Net Leased Properties) 17 For the Six Months Ended June 30, 2026 —
      Trailing 12-months Retention (OM) 65.2% Q2 2026 —
      Same-Store NOI Growth (ISHC) non-GAAP 14.5% Three Months Ended March 31, 2026 —
      Same-Store NOI Growth (Outpatient Medical) non-GAAP 1.6% Three Months Ended March 31, 2026 —
      Same-Store NOI Growth (SHOP) non-GAAP 19.7% Three Months Ended March 31, 2026 —
      Same-Store NOI Growth (Total Portfolio) non-GAAP 12.1% Three Months Ended March 31, 2026 —
      Same-Store NOI Growth (Triple-Net Leased Properties) non-GAAP 4.6% Three Months Ended March 31, 2026 —
      ISHC Same-Store NOI Growth non-GAAP 18.4% Year Ended December 31, 2025 —
      Net Debt-to-Annualized Adjusted EBITDA non-GAAP 3.4 As of December 31, 2025 —
      Outpatient Medical Same-Store NOI Growth non-GAAP 2.1% Year Ended December 31, 2025 —
      SHOP Same-Store NOI Growth non-GAAP 25.2% Year Ended December 31, 2025 —
      Triple-Net Leased Properties Same-Store NOI Growth non-GAAP 0.5% Year Ended December 31, 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      AHR
      American Healthcare REIT, Inc.
      this stock
      		$11.83B +15.4% +9.1% 78.6 10.2%
      WELL
      Welltower Inc.
      		 $162.55B +26.9% +35.6% 114.6 2.5%
      VTR
      Ventas, Inc.
      		 $45.66B +18.3% +18.5% 164.8 4.6%
      DOC
      Healthpeak Properties, Inc.
      		 $14.34B +29.3% +4.5% 59.4 3.5%
      OHI
      Omega Healthcare Investors Inc
      		 $14.10B +4.9% +13.2% 16.6 4.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      559
      % held
      103.1%
      Net QoQ
      +36.4M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      495
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      22.1M
      Days to cover
      9.7d
      Change
      +228.0K sh
      View
      Short Volume
      Short vol %
      42%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      5.2K
      Value
      $286.4K
      As of
      Jul 8, 2026
      View
      Off-Exchange
      Off-exchange %
      46.4%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$1.4M
      Buyers / Sellers
      0 / 2
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $2.3B
      Net income (FY)
      $69.8M
      EPS diluted
      $0.42
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 12, 2026
      This year
      19
      View
      Proposed Sales
      Value
      $97.1K
      Shares
      2.0K
      Filed
      Mar 25, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 7, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      AHR -4.3% -5.0% +3.0% -2.3% +15.4%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -4.7% -9.4% -10.7% -6.2% +1.6%

      Capital returns

      Latest dividend
      $0.25 / share · ex Jun 30, 2026
      Paid (TTM)
      $1.00 / share · 4 payouts
      Dividend yield (TTM, derived)
      1.84%

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1632970 CUSIP 398182303 13F (30d) 523 filings 516 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)